ARCHIVES

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

Kennedy Chooses Health/Education Chair Over Judiciary; No Major Changes In Senate Cancer Policies Expected

November 14, 1986

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

ICCCR Participants Honor Cullen, Blast Tobacco Industry

March 15, 1991

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

‘Be Careful We’re Not Fighting Old Battles’ On Study Section Issue

September 20, 1991